Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 3,075 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke
Interventions: Behavioral Dietary intervention ( MIND Diet), Behavioral Usual Care Diet Intervention; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 55 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke, Ischemia
Interventions: EmboTrap® Revascularization Device; Device
Lead sponsor: Neuravi Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 9
States / cities: Los Angeles, California • San Jose, California • Miami, Florida + 6 more

Conditions: Atherosclerotic Disease, Plaque, Atherosclerotic, Heart Diseases, Stroke, Cardiovascular Risk Factor
Interventions: Ultrasound 3D Imaging; Device
Lead sponsor: Pieter Muntendam; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Lauderhill, Florida

Conditions: Carotid Artery Diseases, Aortic Diseases, Peripheral Arterial Diseases
Interventions: Intergard Standard - Collagen Coated Vascular Grafts and Patches, Hemashield - Collagen Coated Vascular Grafts and Patches, Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches, Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts; Device
Lead sponsor: Intervascular; Industry
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Hershey, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Diabetes, Cancer, Multiple Sclerosis, Arthritis, Parkinson's Disease, Cognitive Disorders, Brain Injury, Stroke
Interventions: Exergame, Home based balance training; Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Stroke
Interventions: Stroke Education Film Viewing, Stroke Education Pamphlet Exposure; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 34 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: New York, New York

Conditions: Plaque, Atherosclerotic, Carotid Artery Plaque, Carotid Stenosis
Interventions: Acoustic Radiation Force Impulse (ARFI) ultrasound; Diagnostic Test
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stroke, Exercise, Sedentary Lifestyle, Ischemic Attack, Transient
Interventions: mHealth-Enhance Physical Activity Intervention, Physical Activity Intervention; Behavioral · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 21 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Depression
Interventions: NSI-189 Phosphate, microcrystalline cellulose capsules; Drug
Lead sponsor: Neuralstem Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Glendale, California

Conditions: Acute Ischemic Stroke
Interventions: RapidPulseTM Aspiration System; Device
Lead sponsor: RapidPulse, Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 18
States / cities: Torrance, California • New Haven, Connecticut • Jacksonville, Florida + 15 more

Conditions: Cerebrovascular Accident
Interventions: LARA, Standard; Device · Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Irvine, California

Conditions: Ischemic Stroke
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Stroke, Acute, Middle Cerebral Artery Stroke, Posterior Cerebral Artery Stroke
Interventions: Human Placenta-Derived Cells PDA001- (cenplacel-L), Placebo; Biological · Drug
Lead sponsor: Celularity Incorporated; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Central Nervous System Disease, Cerebrovascular Accident, Craniocerebral Trauma, Head Injury, Healthy, Stroke
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: Personalized brain state-dependent single-pulse TMS; Device
Lead sponsor: Sara Hussain; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Cerebral Arterial Diseases
Interventions: Dotarem, TOF MRA; Drug · Other
Lead sponsor: Guerbet; Industry
Eligibility: 18 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Brain Disease, Ischemic Attack, Transient, Cerebrovascular Accident, Cerebrovascular Disorder, Vascular Diseases
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Subarachnoid Hemorrhage
Interventions: Sodium nitrite, Saline; Drug
Lead sponsor: Hope Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Intracranial Hemorrhages, Atrial Fibrillation
Interventions: Edoxaban, Non-anticoagulant medical therapy; Drug · Other
Lead sponsor: Population Health Research Institute; Other
Eligibility: 45 Years and older
Enrollment: 948 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 10
States / cities: Elk Grove Village, Illinois • Lisle, Illinois • New Orleans, Louisiana + 7 more

Conditions: Intracranial Atherosclerotic Disease, Stroke, Angioplasty, Balloon, Hemodynamics, Device Safety
Interventions: Submaximal balloon angioplasty; Device
Lead sponsor: Case Western Reserve University; Other
Eligibility: 30 Years to 90 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stroke, Hemispatial Neglect
Interventions: tDCS, sham tDCS, Repetitive task-specific practice (RTP); Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Ischemic Stroke
Interventions: Posturography, Walking Speed, Instrumented 7M Timed UP and GO, Fall Event Records, MRI (3T); Diagnostic Test · Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Muscle Spasticity
Interventions: Baclofen bolus injection; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Stroke, Intracranial Atherosclerosis
Interventions: Ferumoxytol Injectable Product; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

Analysis of Revascularization in Ischemic Stroke With EmboTrap

Natural History of Carotid Plaque as Determined by 3D Ultrasound

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

Tailored Approaches to Stroke Health Education

Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk

The Stroke and Exercise Program

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

Efficacy Study of the LARA Wheelchair System for Subacute Stroke Patients

Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

Brain Processing of Language Meanings

Real-time Personalized Brain State-dependent TMS After Stroke

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Natural History of Stroke: Cause and Development

Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis

Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

Intrathecal (IT) Baclofen Drug Distribution

Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI